CMO/CDMO Biotechnology Market to Reach USD 37.53 Billion by 2033 as Biologics Outsourcing, Integrated Service Models, and U.S.-Asia Capacity Expansion Accelerate Contract Manufacturing Demand

AI Briefing

• – The global CMO/CDMO biotechnology market reached USD 14.32 billion in 2024, up from USD 12.74 billion in 2023.
• – The market is projected to reach USD 37.53 billion by 2033, advancing at a CAGR of 11.3% during 2026-2033.
• – The growth is driven by biologics outsourcing, integrated service models, and U.S.-Asia capacity expansion.